I now have comprehensive, authoritative information to give a complete answer. Here is the full structured response:
Clinical Case Analysis
50-year-old male | Dragging abdominal sensation | Pallor | Massive splenomegaly | No lymphadenopathy | TLC = 1,60,000 cells/mm³ | Platelets = 2 lakhs/mm³
a) Probable Diagnosis: Chronic Myeloid Leukemia (CML)
The clinical triad of massive splenomegaly + marked leukocytosis (1,60,000 cells/mm³) + absence of lymphadenopathy in a middle-aged male is the hallmark presentation of CML. As Robbins & Kumar directly states:
"Sometimes the first symptom is a dragging sensation in the abdomen caused by splenomegaly or the acute onset of left upper quadrant pain due to splenic infarction."
Key supportive features in this case:
- Age: CML peak incidence is in the 5th-6th decade of life
- Massive splenomegaly due to extensive extramedullary haematopoiesis
- TLC of 1,60,000 cells/mm³ - leukocytosis often exceeding 1,00,000 cells/µL is characteristic
- Pallor - reflects mild-to-moderate anaemia from marrow infiltration
- No lymphadenopathy - distinguishes CML from lymphoid malignancies (CLL, lymphoma)
- Platelets 2 lakhs/mm³ - platelets are often normal or elevated in CML chronic phase
This is CML in chronic phase (blasts < 10%).
b) Cytogenetic Change: The Philadelphia (Ph) Chromosome
Primary Cytogenetic Abnormality
t(9;22)(q34;q11) - The Philadelphia Chromosome
In >90% of CML cases, a reciprocal translocation between chromosomes 9 and 22 produces the Philadelphia chromosome:
Fig: Pathogenesis of CML - BCR::ABL fusion gene formation and downstream signaling (Robbins & Kumar, Pathologic Basis of Disease)
| Feature | Detail |
|---|
| Translocation | t(9;22)(q34;q11) |
| Result on Chr 22 | Shortened chromosome 22 = Philadelphia (Ph) chromosome |
| Result on Chr 9 | Elongated chromosome 9 (der 9) |
| Fusion gene | BCR::ABL chimeric gene on der(22) |
| Fusion protein | 210 kDa BCR-ABL constitutively active tyrosine kinase |
| Downstream pathways | RAS, STAT, AKT - drive growth factor-independent proliferation |
| Differentiation | Preserved (unlike AML) - hence mature cells in peripheral blood |
| Frequency | Present in 100% of CML cases (cytogenetically or molecularly) |
Mechanism: The BCR moiety contains a dimerization domain that causes self-association of the fusion protein, leading to constitutive activation of ABL tyrosine kinase without the need for growth factor stimulation. This drives unregulated proliferation of a pluripotent haematopoietic stem cell.
Note: In the ~10% of cases where the Ph chromosome is not visible on karyotyping ("Ph-negative CML"), the BCR::ABL fusion gene is still detectable by FISH or PCR - there is no truly BCR-ABL-negative CML.
Additional Cytogenetic Changes in Disease Progression
As CML transforms to accelerated/blast phase, additional clonal abnormalities may appear:
- Trisomy 8
- Isochromosome 17q
- Duplication of the Ph chromosome
c) Peripheral Blood Smear Findings
| Finding | Detail |
|---|
| Leukocytosis | Marked, often >1,00,000 cells/µL; predominantly granulocytic |
| Neutrophilia | Mature neutrophils and band forms - the dominant cell type |
| Myelocytes | Prominent - the hallmark "myelocyte bulge" in the differential |
| Metamyelocytes | Present in significant numbers |
| Promyelocytes | Present in small numbers |
| Blasts | Usually <10% in chronic phase |
| Eosinophilia | Absolute eosinophilia - a characteristic feature |
| Basophilia | Absolute basophilia - very characteristic of CML; rising basophils signal accelerated phase |
| Anaemia | Normocytic normochromic anaemia |
| Thrombocytosis | Platelets often elevated (sometimes markedly); thrombocytopenia is uncommon in chronic phase |
| Nucleated RBCs | May be seen due to extramedullary haematopoiesis |
| Low LAP score | Leukocyte Alkaline Phosphatase (LAP) score is characteristically low/absent in CML - distinguishes it from leukemoid reaction |
"Myeloid Spectrum" Pattern
The PBS in CML shows a full spectrum of myeloid maturation - from blasts to mature neutrophils - as if the entire bone marrow has "spilled" into the blood. This is unlike a leukemoid reaction (which shows only mature forms and toxic changes) or AML (which shows a maturation arrest with predominantly blasts).
Source: Robbins, Cotran & Kumar - Pathologic Basis of Disease; Goldman-Cecil Medicine; Robbins & Kumar - Basic Pathology